(Q34989242)

English

Evaluation of the validity of preemptive therapy against cytomegalovirus disease based on antigenemia assay with a cutoff of 20 positive cells per two slides

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

Evaluation of the validity of preemptive therapy against cytomegalovirus disease based on antigenemia assay with a cutoff of 20 positive cells per two slides (English)

1 reference

Europe PubMed Central

5 August 2017

Cytomegalovirus

0 references

object named as

Kana Sakamoto

1

0 references

object named as

Junya Kanda

14

0 references

author name string

Hideki Nakasone

2

1 reference

Europe PubMed Central

5 August 2017

Hidenori Wada

3

1 reference

Europe PubMed Central

5 August 2017

Ryoko Yamasaki

4

1 reference

Europe PubMed Central

5 August 2017

Yuko Ishihara

5

1 reference

Europe PubMed Central

5 August 2017

Koji Kawamura

6

1 reference

Europe PubMed Central

5 August 2017

Masahiro Ashizawa

7

1 reference

Europe PubMed Central

5 August 2017

Miki Sato

8

1 reference

Europe PubMed Central

5 August 2017

Kiriko Terasako-Saito

9

1 reference

Europe PubMed Central

5 August 2017

Tomohito Machishima

10

1 reference

Europe PubMed Central

5 August 2017

Shun-ichi Kimura

11

1 reference

Europe PubMed Central

5 August 2017

Misato Kikuchi

12

1 reference

Europe PubMed Central

5 August 2017

Shinichi Kako

13

1 reference

Europe PubMed Central

5 August 2017

Rie Yamazaki

15

1 reference

Europe PubMed Central

5 August 2017

Aki Tanihara

16

1 reference

Europe PubMed Central

5 August 2017

Junji Nishida

17

1 reference

Europe PubMed Central

5 August 2017

Yoshinobu Kanda

18

1 reference

Europe PubMed Central

5 August 2017

language of work or name

0 references

publication date

5 September 2013

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

8

1 reference

Europe PubMed Central

5 August 2017

9

1 reference

Europe PubMed Central

5 August 2017

e73754

1 reference

Europe PubMed Central

5 August 2017

copyright license

Creative Commons Attribution 4.0 International

5 September 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Investigation of the freely available easy-to-use software 'EZR' for medical statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764037

8 July 2018

How we treat cytomegalovirus in hematopoietic cell transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764037

8 July 2018

Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764037

8 July 2018

Definitions of cytomegalovirus infection and disease in transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764037

8 July 2018

Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764037

8 July 2018

Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073754

21 January 2018

Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluation

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073754

21 January 2018

Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073754

21 January 2018

Monitoring cytomegalovirus infection by antigenemia assay and two distinct plasma real-time PCR methods after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073754

21 January 2018

Management of CMV infections: recommendations from the infectious diseases working party of the EBMT.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073754

21 January 2018

Clinical features of late cytomegalovirus infection after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073754

21 January 2018

A randomized controlled trial of plasma real-time PCR and antigenemia assay for monitoring CMV infection after unrelated BMT.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073754

21 January 2018

Pharmacokinetics of ganciclovir in haematopoietic stem cell transplantation recipients with or without renal impairment

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073754

21 January 2018

Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073754

21 January 2018

Pharmacokinetics of ganciclovir after oral valganciclovir versus intravenous ganciclovir in allogeneic stem cell transplant patients with graft-versus-host disease of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073754

21 January 2018

Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. The Fukuoka Bone Marrow Transplantation Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764037

26 October 2018

Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24040054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CMV antigenemia assay using indirect ALP-immunostaining in bone marrow transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24040054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24040054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24040054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8/8 allele-matched unrelated transplantation: a nationwide retrospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24040054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0073754

1 reference

Europe PubMed Central

5 August 2017

2013PLoSO...873754S

0 references

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34989242&oldid=1864069706"